Jump to:
Katherine Fielding is an associate in Ropes & Gray's London office.
Experience
- Eli Lilly in its definitive agreement to acquire Ajax Therapeutics for up to $2.3 billion and on its definitive agreement to acquire Ventyx Biosciences, Inc. for $1.2 billion.
- Pfizer on its acquisition of Metsera for ~$10 billion, including in defence of a bidding war based on antitrust grounds before multiple agencies. This matter was designated Antitrust Matter of the Year in 2026 by Global Competition Review.
- Galderma on the antitrust and foreign direct investment aspects of the acquisition by L’Oreal of an increased equity investment in Galderma.
- EQT on its acquisition of global secondaries firm Coller Capital, in a transaction understood to be the largest-ever secondaries fund manager acquisition.
Credentials
Disclaimer
Ropes & Gray International LLP is a limited liability partnership registered in Delaware, United States of America and is a recognised body regulated by the Solicitors Regulation Authority (with registered number 521000).